Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 1
1959 2
1960 1
1963 4
1964 3
1965 3
1966 3
1967 5
1968 6
1969 3
1970 8
1971 10
1972 4
1973 9
1974 21
1975 9
1976 7
1977 8
1978 7
1979 10
1980 27
1981 6
1982 16
1983 17
1984 27
1985 28
1986 24
1987 31
1988 32
1989 44
1990 43
1991 51
1992 63
1993 66
1994 80
1995 59
1996 73
1997 58
1998 72
1999 66
2000 71
2001 78
2002 89
2003 78
2004 99
2005 55
2006 77
2007 80
2008 75
2009 47
2010 52
2011 48
2012 58
2013 71
2014 87
2015 91
2016 104
2017 97
2018 89
2019 109
2020 124
2021 148
2022 140
2023 123
2024 147
2025 128
2026 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,185 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM.
Ishida T, Kuroda Y, Matsue K, Komeno T, Ishiguro T, Ishikawa J, Ito T, Kosugi H, Sunami K, Nishikawa K, Shibayama K, Aida K, Yamazaki H, Inagaki M, Kobayashi H, Iida S. Ishida T, et al. Among authors: kuroda y. Int J Hematol. 2025 Feb;121(2):222-231. doi: 10.1007/s12185-024-03884-z. Epub 2024 Nov 28. Int J Hematol. 2025. PMID: 39607603 Free PMC article. Clinical Trial.
Transboundary Movement of Yezo Virus via Ticks on Migratory Birds, Japan, 2020-2021.
Nishino A, Tatemoto K, Ishijima K, Inoue Y, Park ES, Yamamoto T, Taira M, Kuroda Y, Virhuez-Mendoza M, Harada M, Nakamura N, Morimoto G, Yamaguchi H, Ariizumi T, Takano A, Shimoda H, Matsuno K, Maeda K. Nishino A, et al. Among authors: kuroda y. Emerg Infect Dis. 2024 Dec;30(12):2674-2678. doi: 10.3201/eid3012.240539. Emerg Infect Dis. 2024. PMID: 39592441 Free PMC article.
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort.
Martin TG, Mateos MV, Yi JH, van de Donk NWCJ, Cai Z, Fu W, Garfall AL, Iida S, Jung SH, Kuroda Y, Niu T, Nooka AK, Min CK, Sidana S, Chastain K, Doyle M, Nishikawa K, Wang X, Song Y, Yamazaki H, Izumi Y, Zhuo J, Zhu A, Yoon DH, Du J, Ishida T. Martin TG, et al. Among authors: kuroda y. Cancer. 2026 Jan 1;132(1):e70237. doi: 10.1002/cncr.70237. Cancer. 2026. PMID: 41485109 Clinical Trial.
Krüppel-like factor 15 deficiency exacerbates osteoarthritis through reduced expression of peroxisome proliferator-activated receptor gamma signaling in mice.
Ikuta K, Hayashi S, Kikuchi K, Fujita M, Anjiki K, Onoi Y, Tachibana S, Suda Y, Wada K, Kuroda Y, Nakano N, Maeda T, Matsumoto T, Hosooka T, Ogawa W, Kuroda R. Ikuta K, et al. Among authors: kuroda y. Osteoarthritis Cartilage. 2024 Jan;32(1):28-40. doi: 10.1016/j.joca.2023.08.009. Epub 2023 Aug 28. Osteoarthritis Cartilage. 2024. PMID: 37648149 Free article.
Real-world effectiveness of belimumab and anifrolumab in systemic lupus erythematosus: comparable trends in disease activity and glucocorticoid reduction.
Sato R, Shimizu M, Kondo Y, Maruo K, Kuroda Y, Ebe H, Yagishita M, Umeda N, Mogi S, Ohyama A, Kitada A, Abe S, Asashima H, Miki H, Tsuboi H, Matsumoto I. Sato R, et al. Among authors: kuroda y. Immunol Med. 2025 Dec;48(4):371-380. doi: 10.1080/25785826.2025.2528296. Epub 2025 Jul 8. Immunol Med. 2025. PMID: 40625101 Free article.
3,185 results